Differences in rates of hypoglycemia and health care costs in patients treated with insulin aspart in pens versus vials

A Review of Diabetes Treatment Adherence and the Association with Clinical and Economic Outcomes

(2011) Carl Asche et al.   CLINICAL THERAPEUTICS

Assessment of adherence and healthcare costs of insulin device (FlexPen®) versus conventional vial/syringe

(2010) Onur Baser et al.   ADVANCES IN THERAPY

Dosing accuracy of commonly used disposable insulin pens

(2010) M. Krzywon et al.   CURRENT MEDICAL RESEARCH AND OPINION

Health Economics and Compliance of Vials/Syringes Versus Pen Devices: A Review of the Evidence

(2010) Carl V. Asche et al.   Diabetes Technology & Therapeutics

Assessment of Patient-Reported Outcomes of Insulin Pen Devices Versus Conventional Vial and Syringe

(2009) Cliff Molife et al.   Diabetes Technology & Therapeutics

Patient satisfaction and costs associated with insulin administered by pen device or syringe during hospitalization

(2008) E. M. Davis et al.   AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY

Economic Costs of Diabetes in the U.S. in 2007

(2008)   DIABETES CARE

Initiating Insulin Therapy in Type 2 Diabetes: Benefits of Insulin Analogs and Insulin Pens

(2008) Stephen Brunton   Diabetes Technology & Therapeutics

Hypoglycaemia in Type 2 diabetes

(2008) S. A. Amiel et al.   DIABETIC MEDICINE